FolioLanternBeta
RVMDRevolution Medicines, Inc.

Elizabeth Anderson

Director at Revolution Medicines, Inc., as of Sep 24, 2026Sold $4.9M of stock in the past 12 months across 2 companies: 40% under a disclosed plan and 60% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
45K
shares held after the latest filing, Revolution Medicines, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
25K
shares sold, past 12 months
3
days with sales
$2.0M
largest single day, Nov 14, 2025
2
companies filed for

Share of stake sold at Revolution Medicines, Inc. is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $3.0M no plan disclosed$3.0MNovDecJanFebMarAprMayJunJulAugSep 2026: $2.0M under a disclosed planSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Revolution Medicines, Inc. (RVMD)DirectorFeb 12, 2020Sep 24, 2026
INSMED Inc (INSM)DirectorNov 8, 2018May 15, 2026

Also a director at

INSMED Inc (INSM)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.